Galectin Therapeutics
GALT
GALT
75 hedge funds and large institutions have $31.1M invested in Galectin Therapeutics in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 77 → 75 (-2)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
75
Holding in Top 10
–
Calls
$442K
Puts
$273K
Top Buyers
| 1 | +$565K | |
| 2 | +$453K | |
| 3 | +$241K | |
| 4 |
Two Sigma Investments
New York
|
+$181K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$159K |
Top Sellers
| 1 | -$120K | |
| 2 | -$118K | |
| 3 | -$111K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$69.4K |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$50K |